Application 090141
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090141-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090141-001 | AB1 |
| A090141-002 | AB1 |
| A090141-003 | AB1 |
| A090141-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090141-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-003 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-004 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-002 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-003 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-004 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-003 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-004 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-002 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-003 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-004 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-003 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-004 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-003 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-004 | AB1 | 1 | 5bbf6a4d5a75… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A090141-001 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-002 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-003 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-004 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-001 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-002 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-003 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-004 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-001 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-002 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-003 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-004 | PC | 2019-03-26 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-001 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-002 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-003 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-004 | PC | 2019-03-26 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | cf353da9-31c6-66c2-e053-2995a90a3bb0 | 2026-01-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f3092f5a-b976-91ab-e053-2995a90a9b50 | 2026-01-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f317fe1e-d7c4-fb8b-e053-2a95a90a5445 | 2026-01-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | 0afd0728-256a-293b-e063-6394a90a3c5f | 2025-12-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f2a132af-d75e-2ca0-e053-2a95a90a332e | 2025-12-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | 0ea97208-5afc-4943-b35c-ea850203a794 | 2025-12-19 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| ADCIRCA | TADALAFIL | United Therapeutics Corporation | ff61b237-be8e-461b-8114-78c52a8ad0ae | 2025-12-15 | Warnings, Adverse reactions | TADALAFIL |
| Tadalafil | TADALAFIL | NIVAGEN PHARMACEUTICALS, INC. | ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a | 2025-12-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Quallent Pharmaceuticals Health LLC | dc14daa3-cae9-4751-9034-b0e9c18054b4 | 2025-11-30 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Quallent Pharmaceuticals Health LLC | 84cb16c8-30ab-49f2-a6df-ec3c97bf6284 | 2025-11-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 6c680b37-d515-4fc2-83e6-411f1017e18c | 2025-10-14 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Ajanta Pharma USA Inc. | 7e4cdac1-42cc-4038-a86b-4890962ed806 | 2025-10-10 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Ajanta Pharma USA Inc. | fceb8aaf-b4eb-4004-8ca4-f004eac6b314 | 2025-10-10 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | PD-RX Pharmaceuticals, Inc. | fc7596dd-42d3-af7c-e053-6294a90af01e | 2025-10-09 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 5de70f00-00ac-4656-883e-d1e07d5f71d6 | 2025-10-09 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | 2354c3e2-7b5f-4fdd-bbf2-7fa3c57686f8 | 2025-09-25 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Preferred Pharmaceuticals Inc. | 66e24ced-0008-40cb-b242-9d9add1f665c | 2025-09-25 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | 761dc0f8-2f65-4615-ab49-a4bcffd40ce9 | 2025-09-25 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Preferred Pharmaceuticals Inc. | 09ad27a1-3908-4533-b84c-7a7fd3514101 | 2025-09-25 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Macleods Pharmaceuticals Limited | 4348b7db-e5b2-4e87-8cdd-674797a18890 | 2025-09-17 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 71205-418 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71610-353 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-354 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 76519-1225 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1226 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1227 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |